Back to AZNCF
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Gastroesophageal Reflux Disease (GERD)
View Full LandscapeDrug Information
Target Indication
Gastroesophageal Reflux Disease (GERD)
Clinical Trial
NCT00468559Last updated: 8/28/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts